PEN-2 Antibodies

Santa Cruz Biotechnology delivers a wide array of PEN-2 monoclonal antibodies for research in understanding PEN-2's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PEN-2, or presenilin enhancer 2, functions as a key component of the gamma-secretase complex, participating in the proteolytic processing of amyloid precursor protein (APP). The processing of APP significantly impacts the production of amyloid-beta peptides, making it particularly relevant to Alzheimer's disease research. Understanding PEN-2's function provides crucial insights into the mechanisms of neurodegenerative diseases and aids in developing potential therapeutic strategies. Researchers can investigate cellular pathways and molecular mechanisms through precise detection and analysis of PEN-2. Advanced research techniques enable detailed examination of PEN-2's involvement in various biological processes. Comprehensive studies of PEN-2 contribute to expanding knowledge in neurobiology and related fields. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of neurodegenerative diseases and potential therapeutic approaches.